PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩300 per share · Prices as of the 2026-10-02 close
SongWon Industrial, which saw a sharp profit decline in 2025, has shown a clear rebound in operating and net profit in the first half of 2026, though governance uncertainty stemming from a previously withdrawn owner-family stake sale remains a lingering variable.
Operating profit in 1Q26 and 2Q26 reached KRW 26.6bn and KRW 39.8bn respectively, each already exceeding the full-year 2025 operating profit of KRW 21.8bn.
2025 was a weak year, with a 4Q operating loss of KRW -3.1bn contributing to a sharp drop in full-year net profit to just KRW 2.3bn.
The debt ratio has steadily improved, falling from 78.3% in 2022 to 50.9% in 2025.
A sale of the owner family's 35.65% stake was pursued in 2023-2024 but withdrawn in early 2024 due to a price gap with bidders.
SongWon reportedly holds one of the leading global market shares in polymer stabilizers (antioxidants), trailing Germany's BASF.
SongWon Industrial is a specialty chemicals materials company founded in 1965 and listed in the KOSPI chemicals sector.
Its business is organized into two segments: an industrial chemicals segment covering polymer stabilizers, antioxidants, organotin compounds and PVC stabilizers, and a functional chemicals segment covering polyurethane resin and plasticizers.
Its core brands include SONGNOX and SONGXTEND, supplying antioxidants, hindered amine light stabilizers (HALS) and UV absorbers as essential additives to polymer manufacturers and compounders.
The company reportedly holds one of the leading global market shares in polymer stabilizers (antioxidants), trailing world No.1 BASF of Germany.
Its domestic production bases are the Ulsan, Maeam and Suwon plants, complemented by overseas manufacturing and distribution subsidiaries in China, Germany, the United States and India.
Its customer base is broadly diversified, spanning domestic petrochemical producers such as LG Chem, Lotte Chemical and Kumho Petrochemical, as well as overseas plastics processors and compounders.
More recently, the company has been expanding into new application areas including fuel and lubricant additives (FLA), electronic materials and functional monomers.
On the governance side, Chairman Park Jong-ho and related owner-family entities hold the controlling stake, and in 2023-2024 a 35.65% stake sale process led by Goldman Sachs was pursued but ultimately withdrawn in early 2024 due to a valuation gap with prospective buyers.
| Quarter | Revenue | Operating profit | Op. margin |
|---|---|---|---|
| 2025Q2 | ₩265.4B | ₩8.6B | 3.2% |
| 2025Q3 | ₩258.6B | ₩5.4B | 2.1% |
| 2025Q4 | ₩239.4B | -₩3.1B | −1.3% |
| 2026Q1 | ₩269.2B | ₩26.6B | 9.9% |
| 2026Q2 | ₩328.5B | ₩39.8B | 12.1% |
| Year | Revenue | Operating profit | Net income (parent) | Op. margin | ROE | Debt-to-equity |
|---|---|---|---|---|---|---|
| 2022 | ₩1.3T | ₩185.1B | ₩131.9B | 13.9% | 19.3% | 78.3% |
| 2023 | ₩1T | ₩58.5B | ₩34.8B | 5.7% | 4.9% | 54.4% |
| 2024 | ₩1.1T | ₩62.8B | ₩45.1B | 5.9% | 6.0% | 56.1% |
| 2025 | ₩1T | ₩21.8B | ₩2.3B | 2.1% | 0.3% | 50.9% |
Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-08-21
On an annual basis, revenue and operating profit peaked in 2022 at KRW 1,329.5bn and KRW 185.1bn (13.9% operating margin), before sharply decelerating to KRW 1,030.0bn in revenue and KRW 58.5bn in operating profit (5.7% margin) in 2023.
In 2024, results recovered modestly to KRW 1,070.2bn in revenue, KRW 62.8bn in operating profit (5.9% margin) and KRW 45.1bn in net profit, only to reverse again in 2025 with revenue of KRW 1,039.2bn, operating profit of KRW 21.8bn (2.1% margin) and net profit shrinking to just KRW 2.3bn.
The quarterly breakdown reveals the depth of the weakness: 2Q25 posted revenue of KRW 265.4bn and operating profit of KRW 8.6bn but a net loss of KRW -1.5bn, while 4Q25 saw revenue fall to KRW 239.4bn with an operating loss of KRW -3.1bn, dragging down the full-year result.
The turnaround became evident in 1Q26, with revenue of KRW 269.2bn, operating profit of KRW 26.6bn and net profit of KRW 18.1bn, followed by an even stronger 2Q26 with revenue of KRW 328.5bn, operating profit of KRW 39.8bn and net profit of KRW 29.6bn, the strongest quarter of the past five.
As a result, cumulative 1H26 operating profit of roughly KRW 66.5bn already exceeds three times the entire 2025 annual operating profit of KRW 21.8bn.
Operating cash flow (CFO) declined from KRW 101.6bn in 2022 and KRW 166.8bn in 2023 to KRW 80.7bn in 2024 and KRW 53.5bn in 2025, reflecting weaker cash generation during the profit downturn. In contrast, the debt ratio improved steadily, falling from 78.3% in 2022 to 50.9% in 2025.
SongWon's core business of polymer stabilizers (antioxidants) is directly tied to global plastics and petrochemical production volumes and processing demand.
The global polymers market is valued at roughly USD 1.4 trillion in 2026, and long-term growth is expected to continue on the back of steady demand from traditional end markets such as construction, automotive and packaging.
However, capacity additions in Asia, particularly China, in recent years have been cited as a source of oversupply and intensified low-price competition that pressures spreads, and the industrial chemicals segment has been assessed as maintaining relatively resilient results despite weaker global demand and heightened competition.
In terms of competitive positioning, SongWon reportedly holds one of the world's leading market shares alongside global No.1 BASF of Germany, and maintains a near-unique position domestically as a large-scale polymer additive specialist.
Because end demand is spread across diverse sectors including automotive, construction, electronics and packaging, dependence on any single industry cycle is relatively limited.
On the other hand, prices of feedstocks such as alkylphenol and isobutylene, along with international crude oil prices and exchange rates, directly affect the cost structure.
Newer application areas such as fuel and lubricant additives (FLA) are seen as offering relatively greater growth potential compared to the traditional polymer stabilizer business.
No official quantitative earnings guidance from the company has been confirmed. That said, given the clear recovery in operating and net profit in 1H26 compared to 2025, whether this momentum continues into the second half will likely be the key focus point for future results.
On the capacity side, the company has been confirmed to be continuously expanding production capacity for polymer stabilizers, fuel and lubricant additives, and coating additives in response to steady growth in the polymer industry.
Among overseas production bases, the Panoli plant in India serves as a hub for high-value-added polymer stabilizers such as antioxidant PQ, and the company appears to maintain a strategy of expanding this site into a global supply chain hub beyond the Indian domestic market.
On governance, following the withdrawal of the 35.65% owner-family stake sale process pursued in 2023-2024, no official announcement of a renewed sale attempt has been confirmed to date.
Whether utilization rates recover among downstream petrochemical and plastics processing customers, along with broader global economic conditions, are considered key variables that could affect results in the second half and beyond.
The recent share price sits at a level that is low relative to the size of shareholders' equity, meaning the price-to-book ratio implies trading at a discount to net asset value.
On the earnings side, while 2025 net profit shrank sharply, both operating and net profit showed a clear recovery trend in 1H26, placing the trailing four-quarter window (3Q25-2Q26) in a period of marked earnings improvement.
The price-to-earnings ratio at which the market currently prices the stock cannot be definitively characterized as being at either the top or bottom of its historical trading band, and this relationship may shift depending on whether the recent earnings recovery persists.
Dividends appear to have been maintained at a certain level even during periods of high earnings volatility, though future dividend sustainability could be linked to the trajectory of results.
Ultimately, how to interpret the relationship between the share price relative to book equity and the durability of the earnings recovery is a matter that may vary by individual investor judgment.
PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-08-21
Operating profit in 1Q26 and 2Q26 reached KRW 26.6bn and KRW 39.8bn respectively, already surpassing the full-year 2025 operating profit of KRW 21.8bn. Net profit also swung to a clear surplus for two consecutive quarters in 2026, in contrast to two loss-making quarters out of four in 2025. This can be read as an early signal of emerging from the 2025 downturn.
SongWon reportedly holds one of the world's leading market shares in polymer stabilizers, trailing global No.1 BASF. Its production bases spanning domestic and overseas locations, along with a diversified customer and regional portfolio, reduce dependence on any single market. Portfolio expansion into new application areas such as fuel and lubricant additives is also underway.
The debt ratio has steadily fallen from 78.3% in 2022 to 50.9% in 2025. Over the same period, shareholders' equity increased from KRW 682.6bn to KRW 760.1bn. Despite earnings volatility, financial stability has continued to improve.
Both 2Q25 and 4Q25 posted net losses, and 4Q25 even saw operating profit turn negative. Such quarter-to-quarter swings indicate relatively low margin stability tied to cost and demand conditions.
Whether the 1H26 recovery reflects a temporary rebound or a structural improvement requires confirmation from additional quarters.
Operating cash flow declined continuously from KRW 166.8bn in 2023 to KRW 80.7bn in 2024 and KRW 53.5bn in 2025. This reflects weakening cash generation during the period of profit deterioration. It remains to be seen whether the recent earnings recovery translates into a recovery in cash flow.
The owner family's proposed sale of a 35.65% stake, which began in June 2023, was withdrawn in early 2024 due to a valuation gap with prospective buyers.
While no official announcement of a renewed sale process has been confirmed since, the history of a repeated attempted sale shows that governance-related uncertainty has not been fully resolved.
Prices of petrochemical feedstocks such as alkylphenol and isobutylene, along with international crude oil price movements, directly affect the cost structure. Weak global petrochemical conditions can translate into spread pressure and margin deterioration. The weak 2025 results are also understood to be linked to such industry cycle factors.
Capacity additions in Asia, particularly China, and the resulting oversupply and intensified low-price competition have been cited as persistent pressure factors. The gap with global No.1 BASF and shifts in the competitive landscape from emerging rivals are also points to monitor.
Given that the owner family pursued a stake sale in 2023-2024, governance and share price-related uncertainty could resurface depending on whether and under what conditions the process is renewed. If a sale is reattempted, uncertainty during price negotiations would also persist.
Check whether 3Q26 results continue the recovery trend seen in Q1 and Q2, and whether the operating margin shows further improvement.
It is worth monitoring DART and other disclosure channels for any renewed owner-family stake sale process or other governance-related announcements.
It is important to continue tracking the impact of international crude oil prices, petrochemical feedstock prices such as alkylphenol, and won-dollar exchange rate movements on costs and spreads.
The progress of capacity expansion plans for polymer stabilizers and fuel/lubricant additives, along with changes in annual utilization rates, should be reviewed.
SongWon Industrial saw a significant pullback in earnings from its 2022 peak through 2023-2025, but has shown clear signs of recovery in both operating and net profit since the first half of 2026. Notably, combined operating profit for 1Q26 and 2Q26 already far exceeds the entire 2025 annual operating profit.
At the same time, net losses in 2Q25 and 4Q25, along with the continued decline in operating cash flow, leave open questions about the quality and durability of earnings. On the financial structure side, improving stability metrics such as the declining debt ratio can be viewed positively.
On governance, the history of a pursued-then-withdrawn owner-family stake sale in 2023-2024 leaves the possibility of a renewed process as a potential variable going forward.
Ultimately, whether results in the second half of 2026 and beyond sustain the recovery momentum seen in the first half, and whether any further governance-related events emerge, are likely to be the key points for understanding this stock.
Report written 2026-09-05 · Data as of 2026-09-04
This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.